What are the most frequently reported adverse reactions to zilucoplan sodium (Zilbrysq) in patients with generalised myasthenia gravis?

The most frequently reported adverse reactions to zilucoplan sodium (Zilbrysq) in generalised myasthenia gravis were injection site reactions (bruising 13.9%, pain 7.0%) and upper respiratory tract infections (nasopharyngitis 5.2%, upper respiratory tract infection 3.5%, sinusitis 3.5%).